Hybrid Closed-Loop (HCL) Therapy for Women With Type 1 Diabetes Who Are Pregnant

Tuesday 8 October 2024 at 12.30-2pm

AIM:

The aim of this webinar is to outline the process and pathways for providing HCL therapy in pregnancy

FOCUS:

The NHS 5-year implementation strategy for HCL technologies
Maximising the benefits of HCL for women with Type 1 diabetes who are pregnant
Practical examples of how maternity services have put HCL onboarding protocols in place
Key considerations for ICS leads

SPEAKERS:

Eleanor M. Scott (Chair) - Professor of Medicine (Diabetes and Maternal Health), University of Leeds & Leeds Teaching Hospitals Trust
Partha Kar - Type 1 Diabetes & Technology Lead. Consultant Diabetes, Portsmouth Hospitals University NHS Trust
Helen R. Murphy - Professor of Medicine, University of East Anglia (UEA), Norwich UK, Honorary Consultant Physician, Norfolk & Norwich University NHS Hospital Trust, Chair National Pregnancy in Diabetes (NPID) audit
Nina Willer - Diabetes Specialist Midwife, Norfolk & Norwich University NHS Hospital Trust
Emma Wilmot – Associate Professor, University of Nottingham School of Medicine, Honorary Consultant Diabetologist,University Hospitals of Derby and Burton. Founder, Diabetes Technology Network UK
Karen Kennedy - Assistant Director, National Diabetes Programme, NHS England

The webinar will be approximately 90 minutes.

A Certificate of Attendance will be issues.